Document is current
Any future updates will be listed below
-
Authors
Liang, Joshua G.
Su, Danmei
Song, Tian-Zhang
Zeng, Yilan https://orcid.org/0000-0001-5777-5702
Huang, Weijin https://orcid.org/0000-0002-4246-8889
Wu, Jinhua
Xu, Rong
Luo, Peiwen
Yang, Xiaofang
Zhang, Xiaodong
Luo, Shuangru
Liang, Ying
Li, Xinglin
Huang, Jiaju
Wang, Qiang
Huang, Xueqin
Xu, Qingsong
Luo, Mei
Huang, Anliang
Luo, Dongxia
Zhao, Chenyan
Yang, Fan
Han, Jian-Bao
Zheng, Yong-Tang https://orcid.org/0000-0001-5469-0324
Liang, Peng https://orcid.org/0000-0001-9107-6323
-
Funding
Funding for this research was provided by:
Coalition for Epidemic Preparedness Innovations (CEPI).
- License Information
-
More Information
Article History
Received: 17 October 2020
Accepted: 3 February 2021
First Online: 1 March 2021
Competing interests
: J.G.L. and P.L. have ownership interest in Clover Biopharmaceuticals. All other authors have no competing interests.
